When depression keeps going despite medication, the question shifts from Why am I still struggling? to how to diagnose treatment resistant depression accurately. That distinction matters, because persistent symptoms do not automatically mean someone has true treatment-resistant depression. Sometimes the issue is the diagnosis itself, the dose, side effects, missed contributors like anxiety or trauma, or simply not having had an adequate trial of treatment.
For patients and families, this stage can feel discouraging. For a psychiatric provider, it is a signal to slow down and evaluate carefully. A good diagnosis is not based on one bad month or one medication that did not work. It is based on a structured review of symptoms, treatment history, medical factors, and whether prior care was truly adequate in dose, duration, and follow-through.
What treatment-resistant depression actually means
In most clinical settings, treatment-resistant depression refers to major depressive disorder that has not improved enough after at least two appropriate antidepressant trials. Appropriate is the key word. A medication only counts as a failed trial if it was prescribed at a therapeutic dose, taken consistently, and continued long enough to judge whether it had a fair chance to work.
That sounds straightforward, but real life usually is not. A patient may stop a medication early because of side effects. Another may take it irregularly because depression affects memory and routine. Someone else may have been given a dose that never reached an effective level. In those cases, the depression may be hard to treat, but it may not yet meet the usual threshold for treatment-resistant depression.
This is why a specialist does not diagnose treatment resistance casually. The label carries weight. It can open the door to advanced treatments such as TMS or Spravato, but it should rest on a complete clinical picture rather than frustration alone.
How to diagnose treatment resistant depression in practice
The process starts with confirming the primary diagnosis. Depression can overlap with bipolar disorder, anxiety disorders, PTSD, ADHD, grief, substance use, personality factors, and medical conditions such as thyroid disease. If the underlying diagnosis is off, treatment may look like it failed when it was never targeting the right problem.
A psychiatrist will usually ask detailed questions about mood, sleep, appetite, concentration, energy, motivation, hopelessness, irritability, and suicidal thinking. They also look at timing. Did symptoms begin after a stressful event? Have there been periods of unusually high energy, less need for sleep, impulsivity, or racing thoughts that might suggest bipolar disorder rather than unipolar depression? In younger patients, irritability and behavioral changes may be more prominent than sadness.
The next step is a careful review of past treatments. This includes which medications were tried, at what dose, for how long, what side effects occurred, and whether there was any partial response. Partial response matters because it often guides what comes next. A medication that helped somewhat may still be useful as part of an adjusted plan, while one that caused significant worsening or no benefit at all may point in a different direction.
Psychotherapy history also matters. Some patients have had excellent medication management but inconsistent therapy. Others have done therapy faithfully without access to updated psychiatric care. Diagnosing treatment-resistant depression is not about proving that nothing works. It is about clarifying which evidence-based treatments have actually been tried and what happened with each one.
What counts as an adequate treatment trial
One of the most common reasons for confusion is that many people have technically tried several medications, but not in a way that qualifies as an adequate trial. In general, clinicians want to see that an antidepressant was taken at a therapeutic dose for long enough, often around six to eight weeks or more once the dose was appropriate, unless side effects made continuation unsafe or unrealistic.
Adherence is part of that assessment. This should be approached without judgment. If a patient missed doses because of nausea, sedation, cost, transportation issues, or simply feeling too overwhelmed, that is clinically important information. It does not mean the patient failed treatment. It means the treatment plan may not have been workable.
This is one reason personalized psychiatric care matters so much. Two patients can have the same diagnosis and very different barriers. One needs a medication change. Another needs side effect management. Another may need a non-medication option because repeated antidepressant trials have been ineffective or poorly tolerated.
Conditions that can look like resistant depression
Before confirming treatment-resistant depression, a provider should rule out factors that can mimic it. Medical contributors are a major example. Thyroid problems, vitamin deficiencies, chronic pain, sleep apnea, hormonal changes, neurologic illness, and some medications can all worsen depressive symptoms.
Substance use can also blur the picture. Alcohol, cannabis, stimulants, and sedatives may temporarily change mood while making depression harder to treat over time. This does not mean a patient is to blame. It means an accurate diagnosis requires honesty about the full pattern of symptoms and coping behaviors.
Another major consideration is bipolar depression. If someone with bipolar disorder is treated only with standard antidepressants, they may not improve as expected, or they may become more agitated, impulsive, or unstable. That is why screening for past mania or hypomania is essential when figuring out how to diagnose treatment resistant depression correctly.
The role of standardized screening and measurement
Experienced psychiatrists do not rely only on a general impression. They often use standardized rating tools to measure symptom severity and track change over time. This can help separate a true nonresponse from a small but meaningful improvement.
Measurement-based care also helps with treatment decisions. If scores show minimal change across multiple appropriate interventions, that supports the case for treatment-resistant depression. If there has been some improvement but not enough, the focus may shift to augmentation, medication adjustment, psychotherapy alignment, or advanced treatment options.
For patients, this approach can be validating. Depression often makes progress hard to notice. Structured assessments create a clearer record of what is happening rather than leaving people to guess whether they are getting better.
When advanced treatment options enter the conversation
Once major depressive disorder is confirmed and at least two adequate antidepressant trials have not produced enough relief, it is reasonable to consider next-step treatments. This is where evaluation becomes especially important. Not every patient needs the same path.
Transcranial magnetic stimulation, or TMS, is an FDA-cleared, non-invasive treatment that uses magnetic pulses to target brain areas involved in mood regulation. It is often considered for adults with depression who have not responded well to medication or who want an option with a different side effect profile. TMS does not require sedation, and patients can return to normal activities after sessions.
Spravato, the nasal spray form of esketamine, may also be considered in certain cases of treatment-resistant depression. It is administered under medical supervision and has specific safety protocols. For some patients, especially those who have struggled through multiple medication trials, it can offer a different mechanism and a more hopeful direction.
A thorough psychiatric practice will not recommend these options simply because standard treatment has been frustrating. The decision should come after diagnostic clarity, medication review, symptom measurement, and discussion of medical history, risks, and goals.
Why specialist evaluation can change the picture
Many patients assume they have run out of options before they have had a true specialist review. In reality, expert evaluation often reveals one of three things: the depression is not actually treatment resistant, the diagnosis needs refinement, or the person is an appropriate candidate for more advanced care.
That distinction is where good psychiatry can make a real difference. Board-certified psychiatric providers look beyond the phrase failed meds and ask more useful questions. Was the diagnosis accurate? Were the trials adequate? Are there co-occurring conditions interfering with recovery? Is the next best step another medication strategy, TMS, Spravato, or a more integrated treatment plan?
For patients in Saginaw and surrounding communities, access to same week evaluations and treatment-focused psychiatric care can shorten the period of uncertainty. When depression has gone on too long, speed matters, but so does precision.
What patients should bring to an evaluation
If you are seeking answers, come prepared with as much treatment history as possible. Medication names, doses, dates, side effects, hospitalizations, therapy history, past diagnoses, and any family history of mood disorders can all help. Even imperfect information is useful.
It also helps to describe what depression looks like in daily life. Are you sleeping all day or barely at all? Are you working but feeling numb, or unable to function at home? Have symptoms changed over time? Those details help a provider assess severity, patterns, and whether the current diagnosis fully fits.
A careful diagnosis does more than assign a label. It creates a safer, more personalized path forward. If depression has continued despite reasonable treatment, that does not mean you are out of options. It means the next step should be smarter, more targeted, and based on a full evaluation rather than trial and error alone.